Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health SystemStephen B. Williams, Stephen J. Freedland, Zachary Klaassen et al.|JAMA Network Open|2021Cited by 62
The impact of the social construct of race on outcomes among bacille Calmette‐Guérin‐treated patients with high‐risk non‐muscle–invasive bladder cancer in an equal‐access settingCorinne Lawler, Stephen B. Williams, Lin Gu et al.|Cancer|2021Cited by 7